Description
Gamma-aminobutyric acid (GABA) is a non-proteinogenic amino acid that serves as the primary inhibitory neurotransmitter in the mammalian central nervous system. It plays a pivotal role in regulating neuronal activity by reducing the excitability of neurons, which contributes to its calming effects and its ability to mitigate anxiety, stress, and fear. GABA is synthesized from glutamate by the enzyme glutamic acid decarboxylase and acts on specific GABA receptors in the brain, namely GABA-A and GABA-B receptors, to decrease the responsiveness of nerve cells.
The health benefits associated with GABA are vast and include its potential to alleviate symptoms of anxiety and mood disorders, as well as its association with the regulation of sleep patterns, which can be beneficial for those suffering from insomnia. Additionally, GABA has been linked to the management of high blood pressure, diabetes, and certain neurological conditions such as epilepsy.
Research also suggests that GABA may have anti-hypertensive, anti-diabetic, anti-cancer, antioxidant, anti-inflammatory, and anti-microbial properties, highlighting its potential in a wide range of pharmaceutical applications. Furthermore, GABA has been found to offer hepato-protective, reno-protective, and intestinal protective effects, indicating its broad therapeutic potential.
Product Name: GABA | |
Synonyms: γ-Aminobutyric acid | |
CAS#: 56-12-2 | |
Molecular Formula: C4H9NO2 | |
Molecular Weight: 103.12 | |
Item | Standard |
Appearance | White to off-white crystals or crystalline powder |
State of solution | Clear |
Identification | Positive |
Chloride (Cl) | Not more than 0.020% |
Sulfate (SO4) | Not more than 0.020% |
Heavy metal(Pb) | Not more than 10ppm |
Arsenic(As2O3) | Not more than 1ppm |
Loss on drying | Not more than 0.30% |
Residueonignition | Not more than 0. 10% |
Assay | Not less than 99.0% |
Lead | Not more than 0.5ppm |
Mercury | Not more than 0. 1ppm |
Melting Range | 197~204℃ |
Residual Solvents | Negative(α-pyrrolidone) |
pH | 6.5 to 7.5 |
Total Plate Count cfu//g | <1000cfu/g |
Yeast & Mold cfu/g | <100 cfu/g |
E.Coli | Negative |
Salmonella | Negative |
Staphylococcus Aureus | Negative |
Coliform | <100 cfu/g |
Bulk density | 0.30~0.52g/ml |
Tap density | 0.50~0.68g/ml |
Particle Size | 100% pass 30 mesh |